Thomas Ireland
Neurology with Special Qualifications in Child Neurology · Chattanooga, TNNPI 1366607327
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $94,613 of the $120,366 with a category attached, or 78.6%. 36 manufacturers reported payments, led by Greenwich Biosciences, Inc. at 32.9% of the total. Among neurology with special qualifications in child neurology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $235.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Greenwich Biosciences, Inc.$40K
- Jazz Pharmaceuticals Inc.$34K
- UCB, Inc.$22K
- Neurelis, Inc.$20K
- Supernus Pharmaceuticals, Inc.$1K
- Neuropace, Inc.$840
- plus $3K from 30 others
What the payments were for
- Consulting fees$8,0007%
- Speaking & faculty fees$94,61379%
- Travel & lodging$7,7756%
- Food & beverage$9,9718%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Greenwich Biosciences, Inc. | 84 | $39,661 |
| Jazz Pharmaceuticals Inc. | 79 | $34,283 |
| UCB, Inc. | 121 | $21,928 |
| Neurelis, Inc. | 51 | $19,693 |
| Supernus Pharmaceuticals, Inc. | 31 | $1,016 |
| Neuropace, Inc. | 3 | $840 |
| Eisai Inc. | 23 | $428 |
| SK Life Science, Inc. | 9 | $252 |
| Acadia Pharmaceuticals Inc | 9 | $227 |
| Sunovion Pharmaceuticals Inc. | 25 | $221 |
| Livanova USA, Inc. | 3 | $216 |
| Immedica Pharma US, Inc. | 8 | $204 |
| Catalyst Pharmaceuticals, Inc. | 7 | $168 |
| Sumitomo Pharma America, Inc. | 10 | $144 |
| Aucta Pharmaceuticals, Inc. | 6 | $143 |
| AbbVie | 6 | $129 |
| Novartis | 5 | $117 |
| Upsher-smith Laboratories LLC | 4 | $94 |
| Biogen | 3 | $70 |
| Genentech USA, Inc. | 2 | $55 |
| Otter Pharmaceuticals, LLC | 2 | $53 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| Sarepta Therapeutics, Inc. | 2 | $52 |
| AstraZeneca | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| Saol Therapeutics Inc. | 2 | $30 |
| NS Pharma, Inc. | 1 | $25 |
| Biocodex, Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Metacel Pharmaceuticals LLC | 1 | $20 |
| Sanofi | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Zogenix Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$71,057
- VALTOCO$18,870
- Nayzilam$11,430
- Fintepla$8,160
- RNS System$775
- OXTELLAR XR$700
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$120
How this compares
$120,366 in reported general payments places this provider in the 90th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.
See all neurology with special qualifications in child neurology providers in Tennessee →
Other neurology with special qualifications in child neurology in Chattanooga
- Day BreenChattanooga$8K
- Lewis MillerChattanooga$8K
- Laura ThomasChattanooga$3K
- Jesus Pina GarzaNashville$1.4M
- James WhelessMemphis$1.2M
- Richard FinkelMemphis$353K
- Jeffrey NeulNashville$127K
- James FryNashville$80K
- Willie AndersonJohnson City$26K
- William BurnetteNashville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.